tenk.fyi

Nuvalent, Inc.

NUVLNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$425.4M

63.1% YoY

EPS

$-5.85

48.9% YoY

Cash

$261.7M

79.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro